RxDoctor Payments Data

Awais Siddique, MD

Vascular & Interventional Radiology · Milwaukee, WINPI 1649387846

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 69.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $8,012 and has fallen 96.4% since, to $289 in 2025.

$13,160in general payments, 2019–2025

Across 101 payments — averaging $130.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$9K
  • Cook Incorporated$990
  • Cook Medical LLC$852
  • Philips North America LLC$652
  • Organogenesis Inc.$321
  • Boston Scientific$251
  • plus $1K from 13 others
$18,004in research payments, 2019–2025

Across 14 payments — averaging $1286.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Veryan Medical Incorporated$15K
  • Bard Peripheral Vascular, Inc.$2K
  • M.a. Med Alliance S.A.$630

What the payments were for

  • Consulting fees$7,00053%
  • Speaking & faculty fees$9908%
  • Travel & lodging$2022%
  • Food & beverage$4,96938%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,160 in reported general payments places this provider in the 80th percentile of 99 vascular & interventional radiology providers in Wisconsin.

See all vascular & interventional radiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$655,202
Medicare patients
1,166
Services billed
2,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate63$724

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →